Gynaecological effects of tamoxifen.
作者信息
Ismail S M
机构信息
Department of Pathology, University of Wales College of Medicine, Cardiff, UK.
出版信息
J Clin Pathol. 1999 Feb;52(2):83-8. doi: 10.1136/jcp.52.2.83.
Abstract
摘要
相似文献
1
Gynaecological effects of tamoxifen.他莫昔芬的妇科效应
J Clin Pathol. 1999 Feb;52(2):83-8. doi: 10.1136/jcp.52.2.83.
2
[Gynecologic monitoring of tamoxifen treatment of breast cancer].[他莫昔芬治疗乳腺癌的妇科监测]
Rev Fr Gynecol Obstet. 1995 Jul-Sep;90(7-9):379-82.
3
Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
J Natl Cancer Inst. 1999 Mar 3;91(5):474-5. doi: 10.1093/jnci/91.5.474.
4
Origin and characteristics of adverse events in aromatase inhibition therapy for breast cancer.乳腺癌芳香化酶抑制治疗中不良事件的起源与特征
Semin Oncol. 2003 Aug;30(4 Suppl 14):58-69. doi: 10.1016/s0093-7754(03)00300-2.
5
[Tamoxifen and endometrial pathology].[他莫昔芬与子宫内膜病理学]
Rev Med Chir Soc Med Nat Iasi. 2010 Oct-Dec;114(4):1114-7.
6
Tamoxifen and the uterus and endometrium.他莫昔芬与子宫及子宫内膜
Lancet. 1989 Feb;1(8634):376.
7
Reply to the Letter to the Editor on "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by I. Cohen Ann Oncol 2005; 16: 1399.对I. 科恩发表于《肿瘤学年鉴》2005年；16卷：1399页的致编辑信“第三代芳香化酶抑制剂可能预防绝经后乳腺癌患者的子宫内膜生长并逆转他莫昔芬引起的子宫变化”的回复
Ann Oncol. 2005 Aug;16(8):1402-3; author reply 1402-3. doi: 10.1093/annonc/mdi237. Epub 2005 May 3.
8
[Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].[他莫昔芬治疗患者采用软性动态宫腔镜检查的子宫内膜病理学对比研究]
Akush Ginekol (Sofiia). 2004;43(3):32-3.
9
Gynaecological aspects of tamoxifen treatment in breast cancer patients.乳腺癌患者他莫昔芬治疗的妇科方面
Cancer Treat Rev. 1997 Sep-Nov;23(5-6):289-304. doi: 10.1016/s0305-7372(97)90029-3.
10
Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology.芳香化酶抑制剂与他莫昔芬诱导的子宫内膜病变的绝经后乳腺癌患者。
Clin Cancer Res. 2006 Sep 15;12(18):5603. doi: 10.1158/1078-0432.CCR-06-0897.
引用本文的文献
1
Feature of amenorrhea in postoperative tamoxifen users with breast cancer.乳腺癌术后服用他莫昔芬患者的闭经特征。
J Gynecol Oncol. 2017 Mar;28(2):e10. doi: 10.3802/jgo.2017.28.e10. Epub 2016 Oct 27.
2
Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report.辅助内分泌治疗后浸润性小叶癌的孤立性子宫转移：一例报告
J Med Case Rep. 2015 Feb 14;9:47. doi: 10.1186/s13256-014-0511-6.
3
Isolated uterine metastasis of invasive ductal carcinoma.浸润性导管癌的孤立性子宫转移
Case Rep Oncol Med. 2013;2013:793418. doi: 10.1155/2013/793418. Epub 2013 Mar 14.
4
Tumorigenic effects of tamoxifen on the female genital tract.他莫昔芬对女性生殖道的致瘤作用。
Clin Med Pathol. 2008;1:17-34. doi: 10.4137/cpath.s487. Epub 2008 Mar 1.
5
Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy.辅助内分泌治疗期间乳腺癌的子宫内膜转移
Case Rep Oncol. 2010 Apr 29;3(2):137-141. doi: 10.1159/000313921.
6
The effect of tamoxifen on the genital tract.他莫昔芬对生殖道的影响。
Cancer Imaging. 2008 Jun 30;8(1):135-45. doi: 10.1102/1470-7330.2008.0020.
7
The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.他莫昔芬对绝经后子宫内膜增殖及类固醇受体表达的影响。
J Clin Pathol. 2002 Jul;55(7):514-9. doi: 10.1136/jcp.55.7.514.
8
Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.第一代选择性雌激素受体调节剂在乳腺癌治疗和预防中的耐受性比较
Drug Saf. 2001;24(14):1039-53. doi: 10.2165/00002018-200124140-00003.
本文引用的文献
1
Endometrial polyps.
Obstet Gynecol. 1956 Jul;8(1):40-9.
2
Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Müllerian tumor) of the uterus?长期他莫昔芬治疗与子宫癌肉瘤（恶性混合性苗勒管肿瘤）的发生之间是否存在关联？
Int J Gynecol Cancer. 1995 Jul;5(4):310-313. doi: 10.1046/j.1525-1438.1995.05040310.x.
3
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.皇家马斯登医院他莫昔芬随机化学预防试验中乳腺癌发病率的中期分析。
Lancet. 1998 Jul 11;352(9122):98-101. doi: 10.1016/S0140-6736(98)85012-5.
4
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.他莫昔芬预防乳腺癌：意大利在子宫切除术后妇女中进行的随机试验的初步结果。意大利他莫昔芬预防研究。
Lancet. 1998 Jul 11;352(9122):93-7. doi: 10.1016/s0140-6736(98)85011-3.
5
Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.在接受他莫昔芬治疗的绝经后乳腺癌患者经阴道超声检查中检测到的异常可能代表子宫内膜囊性萎缩。
Am J Obstet Gynecol. 1998 Jun;178(6):1145-50. doi: 10.1016/s0002-9378(98)70315-1.
6
Tamoxifen downregulates TGF-beta production in keloid fibroblasts.
Ann Plast Surg. 1998 May;40(5):490-3. doi: 10.1097/00000637-199805000-00008.
7
Breast cancer trial stopped early.乳腺癌试验提前终止。
BMJ. 1998 Apr 18;316(7139):1187. doi: 10.1136/bmj.316.7139.1185d.
8
Adjuvant tamoxifen: how long before we know how long?辅助性他莫昔芬：我们要多久才能知道使用时长？
BMJ. 1998 May 16;316(7143):1518-9. doi: 10.1136/bmj.316.7143.1518.
9
Tamoxifen. 'A big deal,' but a complex hand to play.他莫昔芬。“意义重大”，但却是一手难打的牌。
Science. 1998 Apr 10;280(5361):196. doi: 10.1126/science.280.5361.196b.
10
PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium.聚合酶链反应显示，他莫昔芬通过非雌激素机制在人子宫内膜中诱导新型血管生成因子肾上腺髓质素。
Oncogene. 1998 Jan 22;16(3):409-15. doi: 10.1038/sj.onc.1201768.
Zotero 插件